Investor søges - software

<br/>
<p>Microsoft based content collaboration platform. A complete, end-to-end single-source publishing solution that is designed to support the needs of FDA compliant companies acting through the 21 CFR Part 11 requirements.<br /><br /></p>XML technology is emerging as a powerful technology in the pharmaceutical industry. Drug companies and regulatory agencies are looking to speed up the preparation and review of regulatory submissions. For a new drug, one day's sales can equate to one million dollars in revenue. So business drivers are strong to replace today's PDF-based electronic regulatory submissions with smarter XML submissions, as a way to speed time-to-market. <br /><p></p></p><p></p><p></p><p></p><p></p><p></p><p>In non-regulatory areas, pharmaceuticals are implementing XML solutions as a way to derive efficiencies in business functions and enable reuse of their business assets. Session looks at applications where XML technology is being employed in pharmaceutical research &amp; development, manufacturing, and sales &amp; marketing. <br /><br />These include: XML-based status reports, Medical information system call center letters, and Web content management. <p>The use of XML technology will grow in the future to yield business benefit for pharmaceutical companies. <br /><br />We have a very good understanding and knowledge of the FDA regulated market, such as on going dialogs with potential customers which all are among the worlds biggest pharmaceutical companies.<br /><br />We are looking for investors! </p></p><p></p><p></p><p></p><p></p><br/>